Jun Min Wei
President chez CHENGZHI CO., LTD.
Profil
Jun Min Wei is currently the Chief Executive Officer at Peking University Asset Management Co., Ltd.
and a President & Director at Chengzhi Co., Ltd.
He is also a Director at Beijing Peking University WBL Biotech Co. Ltd.
In the past, he worked as the Chairman at China Hi-tech Group Co., Ltd.
Postes actifs de Jun Min Wei
| Sociétés | Poste | Début |
|---|---|---|
| CHENGZHI CO., LTD. | President | 29/09/2022 |
Peking University Asset Management Co., Ltd.
 Peking University Asset Management Co., Ltd. Investment ManagersFinance Peking University Asset Management Co., Ltd. (PKU AM) is the asset management subsidiary of state-owned Ministry of Education's Peking University in China. The firm was established in 2002 and is located in Beijing. | Chief Executive Officer | - |
Beijing Peking University WBL Biotech Co. Ltd.
 Beijing Peking University WBL Biotech Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Peking University WBL Biotech Co. Ltd. is a joint venture company engages in the research, development, production and marketing of natural drugs and modern Chinese medicines. The company leading product are Xuezhikang capsule (XZK) and the lipid-regulating Chinese medicine. The company was was founded on September 1, 1994 and is headquartered in Beijing, China. | Director/Board Member | - |
Anciens postes connus de Jun Min Wei
| Sociétés | Poste | Fin |
|---|---|---|
| CHINA HI-TECH GROUP CO., LTD. | Chairman | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CHINA HI-TECH GROUP CO., LTD. | Transportation |
| CHENGZHI CO., LTD. | Process Industries |
| Entreprise privées | 2 |
|---|---|
Beijing Peking University WBL Biotech Co. Ltd.
Beijing Peking University WBL Biotech Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Peking University WBL Biotech Co. Ltd. is a joint venture company engages in the research, development, production and marketing of natural drugs and modern Chinese medicines. The company leading product are Xuezhikang capsule (XZK) and the lipid-regulating Chinese medicine. The company was was founded on September 1, 1994 and is headquartered in Beijing, China. | Health Technology |
Peking University Asset Management Co., Ltd.
Peking University Asset Management Co., Ltd. Investment ManagersFinance Peking University Asset Management Co., Ltd. (PKU AM) is the asset management subsidiary of state-owned Ministry of Education's Peking University in China. The firm was established in 2002 and is located in Beijing. | Finance |
